Bioethics News

For Autoimmune Ills, Biologics Bring Promise–And Problems

July 12, 2016

(Managed Care Magazine) – Writing on the, a website where people with chronic and mental illness post firsthand accounts, Jessica Hawk-Tillman, a young woman with RA, described vividly the risk–benefit dilemma posed by biologic medications like the ones Frey used: “Without biologic drugs, many people with these diseases cannot perform daily tasks or even get out of bed. With them, our immune systems are suppressed, so we are at a greater risk of developing other illnesses.” Moreover, wrote Hawk-Tillman, biologics often provide just partial relief—and even that modest goal may require enduring the ups and downs of trial and error.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.